Patients with cancer have a high risk of morbidity and mortality from COVID-19. The rapid development of COVID-19 vaccines has provided new hope of mitigating the disease. Herein, the COVID19 and Cancer Clinical Trials Working Group calls for prioritization of patients with cancer, importantly including those participating in oncology clinical trials, for COVID-19 vaccination. The authors also…
The use of artificial intelligence (AI) was a central theme at the 2024 ASCO Annual Meeting, including many tools, such as large language models, clinical…
Vivek Subbiah, MD, of Sarah Cannon Research Institute, explains what areas need to be addressed to make precision oncology more accessible.
Vivek Subbiah: Thrilled to Share My Latest Blog with AACR / AACR, AACR Blog, cancer, Cancer research, OncoDaily, Oncology, Precision Oncology, Research, Vivek
OCE Insights is developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the FDA. In this installment, the authors…
This interim update provides new recommendations for the following ESMO Clinical Practice Guideline (CPG): Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and…
This nonrandomized controlled trial assesses the feasibility of using a circulating tumor DNA−guided adaptive de-escalation tyrosine kinase inhibitor strategy in patients with advanced non−small cell…
OCE Insights is developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the FDA. In this installment, the authors…
Procarbazine induces a higher mutation burden and novel mutational signatures in patients with Hodgkin lymphoma treated with eBEACOPP and their germline DNA, raising concerns for…
Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus / Annals of Oncology, cancer, drug development, OncoDaily, Oncology, Precision
This Viewpoint discusses what a value proposition could look like in oncology and how it should reflect a clinician’s commitment to partner with patients to…
